Hexa Reports Nasopharyngeal Cancer Therapeutics Market Pipeline

Nasopharyngeal Cancer Therapeutics Market Pipeline Review, H2
2017
“Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal
Cancer- Pipeline Review, H2 2017, provides an overview of the
Nasopharyngeal Cancer (Oncology) pipeline landscape.”
Summary
Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer - Pipeline Review, H2 2017,
provides an overview of the Nasopharyngeal Cancer (Oncology) pipeline landscape.
Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of your throat,
behind the nose. This area is called the nasopharynx. The risk factors of nasopharyngeal cancer may include
Epstein-Barr virus. Symptoms of nasopharyngeal cancer may include blurry or double vision, difficulty
speaking, including hoarseness, ear infections that keep coming back, face pain or numbness, headache,
hearing loss, ringing in the ears. Treatment includes surgery, chemotherapy and radiation therapy.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Nasopharyngeal Cancer - Pipeline Review, H2 2017,
provides comprehensive information on the therapeutics under development for Nasopharyngeal Cancer
(Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press releases.
Browse Detail Report With TOC @
https://www.hexareports.com/report/nasopharyngeal-cancer-pipeline-review-h2-2017
Follow Us: